COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 1844: Articles 18431-18440  | Next

Impact of Public Health Education Program on the Novel Coronavirus Outbreak in the United States
Iboi, E. A., Richardson, A., Ruffin, R., Ingram, D., Clark, J., Hawkins, J., McKinney, M., Horne, N., Ponder, R., Denton, Z., Oduro, B., Akinyemi, L.
10.1101/2021.01.18.21250047 — Posted: 2021-01-20
State-of-the-Art Risk Models for Diabetes, Hypertension, Visual Diminution, and COVID-19 Severity in Mexico
Amaya, H., Enciso, J., Meizner, D., Pentland, A., Noriega, A.
10.1101/2021.01.18.21250034 — Posted: 2021-01-20
Analysis of communities of countries with similar dynamics of the COVID-19 pandemic evolution
Alvarez, E., Brida, J. G., Limas, E., Rosich, L.
10.1101/2021.01.18.21250050 — Posted: 2021-01-20
COVID-19 in 823 Transplant patients: A Systematic Scoping Review
Emara, M. M., Elsedeiq, M., Elmorshedi, M., Neamatallah, H., Abdelkhalek, M., Yassen, A., Nabhan, A.
10.1101/2021.01.18.21250025 — Posted: 2021-01-20
The Socioeconomic Impact of COVID-19 in Urban Informal Settlements
Gil, D., Dominguez, P., Undurraga, E. A., Valenzuela, E.
10.1101/2021.01.16.21249935 — Posted: 2021-01-20
Population-scale patient safety data reveal inequalities in adverse events before and during COVID-19 pandemic
Zhang, X., Sumathipala, M., Zitnik, M.
10.1101/2021.01.17.21249988 — Posted: 2021-01-20
Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients
Sperger, J., Shah, K. S., Lu, M., Zhang, X., Ungaro, R. C., Brenner, E. J., Agrawal, M., Colombel, J.-F., Kappelman, M. D., Kosorok, M. R.
10.1101/2021.01.15.21249889 — Posted: 2021-01-20
Estimating Effect-sizes to Infer if COVID-19 transmission rates were low because of Masks, Heat or High because of Air-conditioners, Tests
Sruthi, C. K., Biswal, M. R., Saraswat, B., Joshi, H., Prakash, M. K.
10.1101/2021.01.15.21249896 — Posted: 2021-01-20
Sword of Damocles or choosing well. Population genetics sheds light into the future of the COVID-19 pandemic and SARS-CoV-2 new mutant strains.
Garcia Garcia de Alcaniz, J., Lopez-Rodas, V., Costas, E.
10.1101/2021.01.16.21249924 — Posted: 2021-01-20 Discussion: Onsite
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru
HUAMANI, C., Velasquez, L., Montes, S., Mayanga Herrera, A., Bernabe-Ortiz, A.
10.1101/2021.01.17.21249990 — Posted: 2021-01-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).